Kinetic stabilization of transthyretin through covalent modification of k15 by 3-(5-(3,5-dichlorophenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide Deposition Author(s): Connelly, S. , Grimster, N. , Kelly, J.W. , Wilson, I.A.
Date: 2012-06-08 Method: X-RAY DIFFRACTION Resolution: 1.46 Å Organism(s): Homo Sapiens Sequences Data: 4FI6_A , 4FI6_B
Kinetic stabilization of transthyretin through covalent modification of k15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide Deposition Author(s): Connelly, S. , Grimster, N. , Kelly, J.W. , Wilson, I.A.
Date: 2012-06-08 Method: X-RAY DIFFRACTION Resolution: 1.402 Å Organism(s): Homo Sapiens Sequences Data: 4FI7_A , 4FI7_B
Kinetic stabilization of transthyretin through covalent modification of k15 by 4-bromo-3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide Deposition Author(s): Connelly, S. , Grimster, N. , Kelly, J.W. , Wilson, I.A.
Date: 2012-06-08 Method: X-RAY DIFFRACTION Resolution: 1.22 Å Organism(s): Homo Sapiens Sequences Data: 4FI8_A , 4FI8_B
Human fgf in complex with a covalent inhibitor Deposition Author(s): Aquila, B. , Breed, J. , Debreczeni, J. , Grimster, N. , Kaiser, C. , Mukherjee, H. , Tentarelli, S. , Whitty, A.
Date: 2017-05-26 Method: X-RAY DIFFRACTION Resolution: 1.91 Å Organism(s): Homo Sapiens Sequences Data: 5O49_A , 5O49_B
Human fgf in complex with a covalent inhibitor Deposition Author(s): Aquila, B. , Breed, J. , Debreczeni, J. , Grimster, N. , Kaiser, C. , Mukherjee, H. , Tentarelli, S. , Whitty, A.
Date: 2017-05-26 Method: X-RAY DIFFRACTION Resolution: 2.01 Å Organism(s): Homo Sapiens Sequences Data: 5O4A_A , 5O4A_B